CYP2C19 PHARMACOGENETIC TESTING FOR PERSONALIZATION OF ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN ROUTINE CLINICAL PRACTICE

• المؤلفون الرئيسيون: A. I. Akhmetova (مؤلف), E. B. Kleimenova (مؤلف), D. A. Sychev (مؤلف), O. V. Parshina (مؤلف), L. P. Yashina (مؤلف)
• التنسيق: كتاب
• منشور في: Столичная издательская компания, 2017-12-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Aim. To study the use of CYP2C19 pharmacogenetic testing (PhGT) for personalization of antiplatelet therapy in patients with acute coronary syndrome (ACS) in routine practice.Material and methods. The study included 103 patients with ACS without indications for long-term anticoagulant therapy, which...